SG11201507973TA - Neuroprotective effect of carotenoids in brain - Google Patents

Neuroprotective effect of carotenoids in brain

Info

Publication number
SG11201507973TA
SG11201507973TA SG11201507973TA SG11201507973TA SG11201507973TA SG 11201507973T A SG11201507973T A SG 11201507973TA SG 11201507973T A SG11201507973T A SG 11201507973TA SG 11201507973T A SG11201507973T A SG 11201507973TA SG 11201507973T A SG11201507973T A SG 11201507973TA
Authority
SG
Singapore
Prior art keywords
carotenoids
brain
neuroprotective effect
neuroprotective
effect
Prior art date
Application number
SG11201507973TA
Inventor
Jayant Deshpande
J Shankaranarayanan
Original Assignee
Omniactive Health Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omniactive Health Technologies Ltd filed Critical Omniactive Health Technologies Ltd
Publication of SG11201507973TA publication Critical patent/SG11201507973TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
SG11201507973TA 2013-03-28 2014-03-28 Neuroprotective effect of carotenoids in brain SG11201507973TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/000447 WO2014155189A1 (en) 2013-03-28 2014-03-28 Neuroprotective effect of carotenoids in brain
IN1208MU2013 IN2013MU01208A (en) 2013-03-28 2014-03-28

Publications (1)

Publication Number Publication Date
SG11201507973TA true SG11201507973TA (en) 2015-10-29

Family

ID=50685962

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201507973TA SG11201507973TA (en) 2013-03-28 2014-03-28 Neuroprotective effect of carotenoids in brain

Country Status (12)

Country Link
US (1) US9849096B2 (en)
EP (1) EP2978418A1 (en)
JP (1) JP2016520540A (en)
CN (1) CN105120853A (en)
AU (1) AU2014242655A1 (en)
CA (1) CA2907886A1 (en)
HK (1) HK1211836A1 (en)
IN (1) IN2013MU01208A (en)
MX (1) MX2015013624A (en)
PH (1) PH12015502238A1 (en)
SG (1) SG11201507973TA (en)
WO (1) WO2014155189A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015237806A1 (en) * 2014-03-28 2016-10-20 Omniactive Health Technologies Limited Effect of lipophilic nutrients on diabetic eye diseases
WO2016139605A1 (en) * 2015-03-02 2016-09-09 Omniactive Health Technologies Limited Method for stress management and overall health status improvement and compositions used therein
US9968565B2 (en) 2015-03-02 2018-05-15 Omniactive Health Technologies Limited Method for protection and improvement of liver health with meso-zeaxanthin compositions
KR20180130501A (en) * 2016-02-22 2018-12-07 뉴트리셔스 비브이 Composition for the prevention or treatment of neurodegenerative diseases
CN110691590A (en) * 2017-06-01 2020-01-14 参天制药株式会社 Composition for preventing and/or improving brain dysfunction, containing xanthophyll or its salt and processed product of Trapa plant
GB201720119D0 (en) * 2017-12-04 2018-01-17 Howard Foundation Holdings Ltd Prevention and/or treatment of neurodegenerative disease
GB201801985D0 (en) * 2018-02-07 2018-03-28 Ip Science Ltd Formulation of carotenoids
CA3095341A1 (en) * 2018-03-29 2019-10-03 Avion Pharmaceuticals, Llc Levodopa fractionated dose composition and use
SG10201900604TA (en) * 2019-01-23 2020-08-28 Agency For Science Technology And Research Astarstar Pre-natal beta-cryptoxanthin benefits children
FR3092968B1 (en) * 2019-02-22 2021-05-21 Microphyt DIETARY SUPPLEMENT
FR3117339A1 (en) 2020-12-16 2022-06-17 Naos Institute Of Life Science Use of bacterioruberins and their glycosylated derivatives to prevent and treat diseases involving deregulation of protein aggregation, such as neurodegenerative diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ220599A (en) * 1986-06-16 1990-10-26 Merck & Co Inc Controlled release oral dosage formulation of carbidopa and levodopa
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
DE19609477A1 (en) 1996-03-11 1997-09-18 Basf Ag Stable aqueous solubilisates of carotenoids and vitamins
US7081478B2 (en) 2001-06-29 2006-07-25 Chrysantis, Inc. Mixed zeaxanthin ester concentrate and uses thereof
US20060205826A1 (en) * 2005-03-09 2006-09-14 Romero Francisco J Method of using carotenoids in the prevention of cognitive decline and for other neuroprotection functions
EP1957057A1 (en) 2005-12-07 2008-08-20 Cardax Pharmaceuticals, Inc. Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status
WO2008099469A1 (en) * 2007-02-14 2008-08-21 Tohoku University Composition and method for suppressing lipid peroxidation in erythrocytes
WO2011027209A1 (en) * 2009-09-02 2011-03-10 Omniactive Health Technologies Ltd. A xanthophyl composition containing macular pigments and a process for its preparation
CN102210662A (en) * 2010-04-06 2011-10-12 北京联合大学应用文理学院 Application of lutein in preparation of medicaments for preventing and treating cerebral vascular diseases

Also Published As

Publication number Publication date
WO2014155189A1 (en) 2014-10-02
CN105120853A (en) 2015-12-02
MX2015013624A (en) 2016-06-10
CA2907886A1 (en) 2014-10-02
AU2014242655A1 (en) 2015-10-22
EP2978418A1 (en) 2016-02-03
US9849096B2 (en) 2017-12-26
PH12015502238A1 (en) 2016-02-01
HK1211836A1 (en) 2016-06-03
US20160051490A1 (en) 2016-02-25
JP2016520540A (en) 2016-07-14
IN2013MU01208A (en) 2015-07-03

Similar Documents

Publication Publication Date Title
IL287516A (en) Therapeutic uses of empagliflozin
HRP20190101T1 (en) Therapeutic uses of empagliflozin
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
GB2530455B (en) Methods of bleaching hair
HK1211836A1 (en) Neuroprotective effect of carotenoids in brain
HK1213818A1 (en) Therapeutic uses of empagliflozin
PT2941163T (en) Skin cleanser
GB201317889D0 (en) Product and use
IL286759A (en) Therapeutic methods and compositions
EP2968474A4 (en) Skin compositions and uses
LT2981271T (en) Therapeutic uses of empagliflozin
GB2540853B (en) Beauty product displays
GB201301639D0 (en) Product and process
HK1224307A1 (en) Protoxin-ii variants and methods of use -ii
EP3015100A4 (en) Cosmetic
HK1219294A1 (en) Compositions and methods for reducing skin pigmentation
HK1188366A2 (en) One type of massager
GB201412374D0 (en) Articl of headgear
GB201304585D0 (en) Methods and product
GB201301834D0 (en) Hair nutrition
GB201319255D0 (en) Therapeutic compositions and methods
GB201309328D0 (en) Product and use thereof
GB201311054D0 (en) Beady eyes